
Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

